TAKEDA PHARMACEUTICA

4502
End-of-day quote. End-of-day quote  - 09/18
3989JPY +0.99%

Takeda Pharmaceutical : Japan's Takeda to sell TachoSil surgical patch to Corza Health for 350 million euros

09/16/2020 | 03:37am

Takeda Pharmaceutical Co said on Wednesday it would sell its TachoSil surgical patch product to Corza Health for 350 million euros ($414.75 million) as the Japanese company continues to divest non-core businesses.

TachoSil, a surgical patch used for bleeding control

control, delivered $160 million in sales for Takeda in the fiscal year ended March 31, 2020, the company said in a release.

To reduce debt, Takeda has pledged to dispose of $10 billion worth of non-core assets.

Takeda is focusing on five key business areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies.

($1 = 0.8439 euros)

(Reporting by Rocky Swift, editing by Louise Heavens)

© Thomson Reuters 2020
Copier lien
All news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
2d ago
2d ago
3d ago
3d ago
3d ago